Article contributed to PharmaLeaders and authored by: Jeremy Lovelace, founder and director of HFX Training. Across all industries, sales teams face an uncertain future, and pharma is no different. Many key sales practices, such as healthcare provider meetings and terrority-focused engagement have been replaced by the unfamiliar environment of zoom calls, … [Read more...]
Healthcare M&A on the Rise: 5 Principles for Creating a New Brand that Resonates
Article contributed to PharmaLeaders by Matt Egan, Executive Director, Strategy at Siegel+Gale A wave of M&A deals is coming to the healthcare industry. According to consulting firm BDO, 44% of healthcare CFOs are expecting to drive an increase in partnerships across the healthcare ecosystem and 42% are predicting further consolidation. The pandemic accelerated digital … [Read more...]
Patient-Centered Approaches to Clinical Research in Oncology
Article contributed to PharmaLeaders by Edward F. Ikeguchi, M.D., the Chief Executive Officer at AiCure Most of us have personal experiences with cancer, whether ourselves or with loved ones. We know that cancer is frightening and that treatment regimens can be stressful, exhausting and overwhelming. Patients participating in drug trials for oncology are subject to a list of … [Read more...]
How to use digital platforms to engage with your customers
Article contributed to PharmaLeaders by Rachel Murray, Head of Partnerships, Fountain Partnership The last year has seen the Pharma industry propelled into the digital world in order to deliver clear communication to healthcare professionals and customers. Traditionally reliant on face-to-face communication, including selling, the Covid-19 pandemic has accelerated online … [Read more...]
How Natural Language Processing Unlocks the Full Healthcare and Patient Journey
Contributed to PharmaLeaders by Authors: By Ana Bargo, M.S.; Jeannine Cain, MSHI, RHIA, CPHI; Shannon Fee, B.A.; Mark Yap, FNP-C In 2016, a major transformation occurred in how we evaluate clinical data for real-world effectiveness. The FDA signed into law the 21st Century Cures Act, which impacted the Real-World Evidence Program in the U.S. It signaled a paradigm shift in … [Read more...]